# Ramón Salazar

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ramon-salazar/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,388 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 71 |
| i10-index | 193 |
| Last Known Institution | Institut d'Investigació Biomédica de Bellvitge |
| OpenAlex ID | https://openalex.org/A5035175323 |
| ORCID iD | https://orcid.org/0000-0001-9419-6232 |
| Works | 636 |

## Researcher papers

- [Gastroenteropancreatic neuroendocrine tumours](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-tumours/)
- [Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/short-course-radiotherapy-followed-by-chemotherapy-before-total-mesorectal/)
- [ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site](https://scholariq.org/papers/enets-consensus-guidelines-update-for-the-management-of-distant-metastatic/)
- [ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary](https://scholariq.org/papers/enets-consensus-guidelines-for-the-management-of-patients-with-liver-and-other/)
- [Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids](https://scholariq.org/papers/pulmonary-neuroendocrine-carcinoid-tumors-european-neuroendocrine-tumor-society/)
- [Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer](https://scholariq.org/papers/gene-expression-signature-to-improve-prognosis-prediction-of-stage-ii-and-iii/)
- [ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas](https://scholariq.org/papers/enets-consensus-guidelines-for-the-management-of-patients-with-neuroendocrine/)
- [MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling](https://scholariq.org/papers/med12-controls-the-response-to-multiple-cancer-drugs-through-regulation-of-tgf/)
- [Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial](https://scholariq.org/papers/oxaliplatin-fluorouracil-and-leucovorin-with-or-without-cetuximab-in-patients/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)

## Researcher university

- [Institut d'Investigació Biomédica de Bellvitge](https://scholariq.org/institutions/institut-d-investigacio-biomedica-de-bellvitge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.